rs199472884
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PP3_ModeratePP5_Very_StrongBS2_Supporting
The NM_000238.4(KCNH2):c.916G>T(p.Gly306Trp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000632 in 1,108,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000238.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.916G>T | p.Gly306Trp | missense_variant, splice_region_variant | 4/15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.916G>T | p.Gly306Trp | missense_variant, splice_region_variant | 4/15 | 1 | NM_000238.4 | ENSP00000262186.5 | ||
KCNH2 | ENST00000532957.5 | n.1139G>T | splice_region_variant, non_coding_transcript_exon_variant | 4/9 | 2 | |||||
KCNH2 | ENST00000684241.1 | n.1749G>T | splice_region_variant, non_coding_transcript_exon_variant | 2/13 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000632 AC: 7AN: 1108190Hom.: 0 Cov.: 31 AF XY: 0.00000762 AC XY: 4AN XY: 525060
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 10, 2016 | The G306W variant in the KCNH2 gene has been reported in at least one individual with LQTS and has not been observed in >1000 control alleles (Tester D et al., 2005; Kapa et al., 2009; Giudicessi et al., 2012). Of note, coverage of this nucleotide position in these control alleles was not reported, and presence or absence in the NHLBI Exome Sequencing Project was unable to be determined due to inadequate coverage (1X). This variant was also seen co-segregating with LQTS in four relatives referred for genetic testing at GeneDx. Additionally, G306W is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. The Guanine nucleotide at position c.916 is the 3'-terminal nucleotide of exon 4, and two out of three splicing algorithms suggest that this nucleotide substitution either damages or destroys the canonical splice donor site at this exon/intron junction. Other missense variants in KCNH2 that are predicted to affect splicing have been reported in the Human Genome Database (HGMD) in association with LQTS (Stenson et al., 2014). Lastly, a variant at the same residue (G306R) has also been reported in HGMD in association with LQTS. Therefore, G306W is a strong candidate to be pathogenic. Nevertheless, additional segregation and functional studies are necessary to clarify the role of this variant in disease. - |
Long QT syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 13, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 306 of the KCNH2 protein (p.Gly306Trp). This variant also falls at the last nucleotide of exon 4, which is part of the consensus splice site for this exon. This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with clinical features of long QT syndrome (PMID: 22949429; Invitae). ClinVar contains an entry for this variant (Variation ID: 67544). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the c.916G nucleotide in the KCNH2 gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 15840476, 18752142; Invitae). This suggests that this nucleotide is clinically significant, and that variants that disrupt this position are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Congenital long QT syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:15840476;PMID:19841300). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at